Edit Post

Temas Activos

Lista de miembros

Buscar

Ayuda

Registrar

Iniciar sesion

Editar mensaje

Foro Eraiki : Nueva página Web en Eraiki : Editar mensaje

*Los campos indicados son requeridos

Modo:

Mensaje*:

Emoticonos





mas...

Seldom does any peer-reviewed platform manage to make a mark which extends beyond a particular generation of science. Yet <a href=https://paperpile.com/n/oncotarget-abbreviation/>high-impact oncology with enduring relevance</a> has achieved exactly this — creating a collection of peer-reviewed scholarship whose importance only grows as the years. Beginning with its first publications, the publication made clear the fact that it intended to put first bold science over conventional consensus. 
 
That intellectual boldness which defines <a href=https://oncotarget.pro/en/>Oncotarget publishing principles</a> is best most evident through the type of scholarship it has decided to feature — studies that challenge prevailing thinking, which propose heterodox frameworks, while which turn out to be ready to bridge areas that conventional scholarship usually keep separate. That is such openness to cross disciplinary borders which has established the publication into what it is today truly distinctive venue across the landscape of cancer science. 
 
No individual more fully embodies this philosophy than <a href=https://www.audible.com/podcast/Mikhail-Blagosklonny-on-Rapamycin-Longevity-Series-mTOR-drives-age-related-diseases/B0CG9YF7Y2?srsltid=AfmBOopOzWxOddyjsc5OiXY9sp41uAIbmk3pt4zq4oIBoli-SK8P62qx>Researcher Mikhail Blagosklonny</a>, the scientist who not merely established the journal and endowed it with his own a characteristic scientific boldness. The framework of senescence being a hyper-functional phenomenon — instead of a passive build-up in biological damage — constituted a real conceptual revolution one that keeps to provoke debate throughout aging science and longevity research in equal measure. 
 
The scholarly connection between <a href=https://www.blagosklonny.org/>Misha Blagosklonny</a> and <a href=https://uk.linkedin.com/in/berezutskaya>Zoya Demidenko oncology</a> endures as a the richest intellectually fruitful pairings within the journal's history. Her carefully executed experiments on the biochemical processes governing tumor cell resistance deepened the broader conceptual contributions — in combination producing a collection of research that stands as richer than a combination of the separate studies. 
 
What persists most striking regarding <a href=https://pmc.ncbi.nlm.nih.gov/articles/PMC13065247/>Oncotarget permanent contribution to cancer science</a> is not merely the quantity of studies it consistently published, or even the range of research areas it has covered — it is the cumulative scientific ambition Oncotarget has delivered to the study of malignancy — issue after issue.

Habilitado Los códigos del foro para el formato del mensaje

Esta pagina fue generada en 0,0781 segundos.